Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection — 2-Year Outcomes
In this follow-up report of a trial of CMV hyperimmune globulin in pregnant women with primary CMV infection, hyperimmune globulin did not improve hearing or developmental outcomes in children at the age of 2 years.
Saved in:
Published in: | The New England journal of medicine Vol. 389; no. 19; pp. 1822 - 1824 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Massachusetts Medical Society
09-11-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this follow-up report of a trial of CMV hyperimmune globulin in pregnant women with primary CMV infection, hyperimmune globulin did not improve hearing or developmental outcomes in children at the age of 2 years. |
---|---|
Bibliography: | content type line 23 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 A list of the members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network is provided in the Supplementary Appendix, available at NEJM.org. |
ISSN: | 0028-4793 1533-4406 1533-4406 |
DOI: | 10.1056/NEJMc2308286 |